30.08.2011 • NewsMerckMerck Millipore

Merck Millipore Acquiring Amnis

Merck Millipore has agreed to acquire Seattle-based Amnis Corporation. Amnis designs, manufactures and markets high speed cell imaging instrumentation. The technology is used in flow cytometry applications in academic, biotech and pharmaceutical cell analysis and research. Amnis has 40 employees and generated sales of $14 million (€10 million) in 2010.

The transaction is subject to regulatory approvals and closing is expected to take place in the fourth quarter of 2011. Terms of the transaction were not disclosed.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.